Intelligence · Patents
Patents expiring in 2027
Annual patent cliff calendar for 2027 — US pharmaceutical patents by expiration date.
- Patents
- 599
Quick answer
599 indexed pharmaceutical patents have expiration dates in 2027. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 7282205
Anti-hepatitis A virus antibodies
granted -
US 7285639
Antibody to telomerase reverse transcriptase
granted -
US 7285668
Process for the crystallization of (R)- or (S)-lansoprazole
granted -
US 7285556
Thienopyrimidine-based inhibitors of the src family
granted -
US 7285542
Hyperthermic inducible expression vectors for gene therapy and methods of use thereof
granted -
US 7285281
Mutant forms of cholera holotoxin as an adjuvant
granted -
US 7285683
Bicyclic and tricyclic cannabinoids
granted -
US 7285363
Photoactivators, methods of use, and the articles derived therefrom
granted -
US 7285564
Substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds
granted -
US 7285415
Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
granted -
US 7285534
Corticotropin-releasing hormone analogs and their uses
granted -
US 7285527
Tumor radiosensitization using gene therapy
granted -
US 7285383
Method for selective inactivation of viral replication
granted -
US 7285532
Therapeutic method for treating bone formation diseases
granted -
EP 1847258
Partialglyceride als Schmiermittel für pharmazeutische Zusammensetzungen enthaltend Thieno[3,2-c]pyridin-Derivate
granted -
US 7288254
Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation
granted -
US 7288654
Fused-ring pyridine derivative, process for producing the same, and use
granted -
US 7288624
Inhibitors of interleukin-1β converting enzyme
granted -
US 7288671
Interleukin-1 and tumor necrosis factor-α modulators, synthesis of said modulators and their enantiomers and methods of using said modulators
granted -
US 7288246
Method of alleviating chronic pain via peripheral glutaminase regulation
granted -
US 7288266
Liposome complexes for increased systemic delivery
granted -
US 7288369
Replication competent hepatitis C virus and methods of use
granted -
US 7288258
Polyepitopic protein fragments of the E6 and E7 proteins of HPV, their production and their use particularly in vaccination
granted -
US 7288263
Compositions and methods for treatment of skin discoloration
granted -
US 7288608
Degradable thiol-ene polymers
granted -
US 7288657
Biphenyl compounds useful as muscarinic receptor antagonists
granted -
US 7288646
USPA2 nucleic acid of Moraxella catarrhalis
granted -
AU 2007242062
Pharmaceutical compositions of oxcarbazepine with a median particle size of 15 to 30 microns
granted -
CA 2648495
FORMULATIONS A LIBERATION CONTROLEE QUI COMPRENNENT UNE OU PLUSIEURS UNITES DISCRETES NON ENROBEES ET UNE MATRICE A LIBERATION RETARDEE
granted -
US 7291603
Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations
granted -
US 7291611
Benzimidazolidinone derivatives as muscarinic agents
granted -
US 7291614
Processes for the preparation of linezolid intermediate
granted -
US 7291348
Compositions and methods for biodegradable microspheres as carriers of bioactive substances
granted -
IT MI20070164
CEROTTO TRANSDERMICO
granted -
US 7291336
Compositions and methods for enhancing immune responses mediated by antigen-presenting cells
granted -
US 7291699
Product and methods for diagnosis and therapy for cardiac and skeletal muscle disorders
granted -
US 7294735
Purification of cinacalcet
granted -
US 7294475
Gene and use thereof
granted -
US 7294687
Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus
granted -
US 7294480
High throughput screening assays using fatty acid synthetic enzymes
granted -
US 7294344
Sustained-release preparation for AII antagonist, production and use thereof
granted -
US 7294496
Cloned human lysophospholipase
granted -
US 7294699
Modified vitamin K-dependent polypeptides
granted -
US 7297523
Human elongase genes and uses thereof
granted -
US 7297488
Identifying and testing antisense oligonucleotides that inhibit telomerase reverse transcriptase
granted -
US 7300774
Multimeric fusion proteins of the TNF superfamily ligands
granted -
US 7300949
Thiazolopyrazoles and methods of their use
granted -
US 7301024
Crystalline forms of gatifloxacin and processes for preparation
granted
Frequently asked questions
How many pharma patents expire in 2027?
599 published patents in our USPTO index have expiration dates falling in calendar year 2027.